TGF-beta2 silencing to target biliary-derived liver diseases. Dropmann A, Dooley S, Dewidar B, Hammad S, et al. Gut 2020 Jan 28. pii: gutjnl-2019-319091. doi: 10.1136/gutjnl-2019-319091.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dropmann A, Dooley S, Dewidar B, Hammad S, et al. TGF-beta2 silencing to target biliary-derived liver diseases. Gut 2020 Jan 28. pii: gutjnl-2019-319091. doi: 10.1136/gutjnl-2019-319091.
PMID: 31992593